NDC product
Ustilago Maidis
NDC 37662-2109 · Hahnemann Laboratories, INC.
Key facts
| Product NDC | 37662-2109 |
|---|---|
| Proprietary name | Ustilago Maidis |
| Nonproprietary name | Ustilago Maidis |
| Substances | USTILAGO MAYDIS |
| Dosage form | PELLET |
| Route | ORAL |
| Labeler | Hahnemann Laboratories, INC. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC] |
| Marketing start | Dec 14, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: